Condition: Mild Cognitive Impairment (MCI) · Major Depressive Disorder, Remitted · Healthy Controls Group - Age and Sex-matched · Sponsor: Centre for Addiction and Mental Health
The goal of this observational study is to validate the Creyos online cognitive assessment platform in individuals with mild cognitive impairment, or remitted major depressive disorder. The main objectives of this research are: 1. To confirm the feasibility of administering the Creyos cognitive battery to older adults with Mild Cognitive Impairment MCI) or Major Depressive Disorder in remission (rMDD). 2. To determine whether the Creyos battery can detect changes in cognition that are predictive of changes on paper-and-pencil neuropsychological testing ("gold standard") over up to five years. Participants will complete both in-person neuropsychological testing yearly as well as the Creyos online battery quarterly for up to 5 years, to allow us to compare performance on these two batteries over time.
This description comes directly from the study's public registry record.
Benoit H. Mulsant, MD · 416-583-1350 · benoit.mulsant@utoronto.ca
Heather Brooks, PhD · 416-583-1350 · CreyosMD@camh.ca
Always discuss trial participation with your own doctor first.
| St. Michael's Hospital | Toronto, Ontario, Canada | Recruiting |
| University Health Network | Toronto, Ontario, Canada | Recruiting |
| Centre for Addiction and Mental Health | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06780917